COMPX DECLARES REGULAR QUARTERLY DIVIDEND
11/05/2025 04:15 PM • CompX International Inc. announced a quarterly dividend of $0.30 per share, payable on December 9, 2025, to stockholders of record as of November 21, 2025.
11/05/2025 04:15 PM • CompX International Inc. announced a quarterly dividend of $0.30 per share, payable on December 9, 2025, to stockholders of record as of November 21, 2025.
11/05/2025 04:15 PM • Farmer Mac announced quarterly dividends of $1.50 per share for common stock and varying dividend rates for five preferred stock classes, payable in late December 2025 and January 2026.
11/05/2025 04:15 PM • Clarus Corporation announced a quarterly cash dividend of $0.025 per share, to be paid on November 26, 2025, to stockholders of record as of November 17, 2025.
11/05/2025 04:10 PM • Advanced Energy Industries reported strong Q3 earnings, with 80% year-over-year profit growth and 24% total revenue increase, driven by significant AI data center solutions sales growth of 113%.
11/05/2025 04:10 PM • Firefly Aerospace has successfully completed its acquisition of SciTec, a national security technology company, for a combination of cash and stock. The strategic purchase adds advanced defense software capabilities, big data processing expertise, and over 475 employees to Firefly's space and defense technology portfolio.
11/05/2025 04:05 PM • Scotts Miracle-Gro announced a quarterly cash dividend of $0.66 per share, payable on December 5, 2025, to shareholders of record as of November 21, 2025.
11/05/2025 04:05 PM • Devon Energy reported its third-quarter 2025 financial and operational results, held a conference call for analysts and investors, and declared a quarterly dividend. The company highlighted its multi-basin portfolio and disciplined cash-return business model.
11/05/2025 04:01 PM • Roper Technologies announced a quarterly cash dividend increase of 10% to $0.91 per share, marking its 33rd consecutive annual dividend increase, payable on January 16, 2026.
11/05/2025 04:01 PM • Dynavax reported strong Q3 2025 financial results, with HEPLISAV-B vaccine revenue increasing 13% to $90 million. The company entered an exclusive license agreement with Vaxart for an oral COVID-19 vaccine and authorized a new $100 million share repurchase program.
11/05/2025 04:00 PM • Cytokinetics reported strong progress towards potential FDA approval of aficamten for hypertrophic cardiomyopathy by December 26, 2025, with ongoing regulatory reviews in the U.S., China, and E.U. The company maintains a strong cash position of $1.25 billion and continues advancing multiple cardiac muscle treatment programs.
11/05/2025 04:00 PM • Richard Crawford, senior director of federal government affairs at Molson Coors, was honored with the 2025 Jeff Becker Beer Industry Service Award for his 35-year dedication to the beer industry, including advocacy for fair policies and responsible marketing.
11/05/2025 04:00 PM • Acumen Pharmaceuticals will report its Q3 2025 financial results on November 12, 2025, hosting a conference call and webcast to provide a business and financial update. The company is developing a novel therapeutic targeting toxic amyloid beta oligomers for Alzheimer's disease treatment.
11/05/2025 04:00 PM • OTC Markets Group will report its Q3 2025 financial results on November 12, 2025, followed by a conference call and webcast on November 13, 2025, where management will discuss the results in detail.
11/05/2025 04:00 PM • Dynavax Technologies has entered an exclusive worldwide license agreement with Vaxart to develop and commercialize an oral COVID-19 vaccine candidate, paying $25 million upfront and investing $5 million in equity, with potential future milestone payments.
11/05/2025 03:56 PM • A class action lawsuit has been filed against Synopsys alleging the company misled investors about its IP business performance, with stock price dropping 35.8% after revealing underperforming financial results.
11/05/2025 03:53 PM • Troilus Gold Corp. has secured an agreement with underwriters to raise approximately $150 million through a share offering to fund its Troilus Copper-Gold project development, debt repayment, and corporate purposes.
11/05/2025 03:45 PM • GreenPower Motor Company is voluntarily delisting from the TSX Venture Exchange due to low trading volumes, high compliance costs, and a strategic focus on streamlining operations while maintaining its NASDAQ listing.
11/05/2025 03:35 PM • Altria experienced a 15% stock decline in October due to weak Q3 earnings, declining cigarette shipments, and challenges in transitioning to next-generation products amid consumer spending pressures.
11/05/2025 03:09 PM • Rigetti Computing, a vertically integrated quantum computing company, has seen significant stock gains, but faces challenges from big tech competitors like Alphabet and IBM. While promising, the stock remains highly speculative with uncertain commercial viability.
11/05/2025 03:08 PM • Lemonade experienced a significant stock price increase of over 30% after reporting strong quarterly results, with potential for further price movement in the coming days.
11/05/2025 03:01 PM • O-I Glass reported strong Q3 earnings, beating analyst estimates with flat net sales and a significant improvement in net income. The company raised its full-year earnings guidance, driving a 14% stock price surge.
11/05/2025 03:00 PM • EdgeAI launches a decentralized edge intelligence network connecting over 20,000 industrial and maritime devices across Asia, leveraging Tagvance's IoT infrastructure to enable autonomous machine learning and collaboration.
11/05/2025 02:53 PM • Check Point Software achieved a 99.59% security effectiveness rating in NSS Labs' 2025 Enterprise Firewall test, outperforming competitors with exceptional exploit and malware block rates amid rising AI-driven cyber threats.
11/05/2025 02:49 PM • Planet Fitness is distributing 500 free frozen turkeys to local residents in Decatur and Stone Mountain, Georgia, on November 24, 2025, as part of its annual community support initiative.
11/05/2025 02:46 PM • MediaAlpha reached a $45 million settlement with the Federal Trade Commission involving additional disclosures and content review processes for under-65 health websites, which negatively impacted its stock price.